Human immunodeficiency virus reverse transcriptase and protease sequence database

被引:61
|
作者
Shafer, RW [1 ]
Jung, DR
Betts, BJ
Xi, YO
Gonzales, MJ
机构
[1] Stanford Univ, Med Ctr, Div Infect Dis, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Engn, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
关键词
D O I
10.1093/nar/28.1.346
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV RT and Protease Sequence Database is an online relational database that catalogs evolutionary and drug-related human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease sequence variation (http://hivdb.stanford.edu), The database contains a compilation of nearly all published HIV RT and protease sequences including International Collaboration database submissions (e.g., GenBank) and sequences published in journal articles, Sequences are linked to data about the source of the sequence sample and the antiretroviral drug treatment history of the individual from whom the isolate was obtained, The database is curated and sequences are annotated with data from >230 literature references. Users can retrieve additional data and view alignments of sequence sets meeting specific criteria (e.g,, treatment history, subtype, presence of a particular mutation), A gene-specific sequence analysis program, new user-defined queries and nearly 2000 additional sequences were added in 1999.
引用
收藏
页码:346 / 348
页数:3
相关论文
共 50 条
  • [21] Simultaneous separation of fifteen approved protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by capillary electrophoresis
    Tuan, ND
    Gutleben, W
    Scherer, K
    Stoiber, H
    Falkensammer, B
    Dierich, MP
    Zemann, A
    ELECTROPHORESIS, 2003, 24 (04) : 662 - 670
  • [22] Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication
    Deminie, CA
    Bechtold, CM
    Stock, D
    Alam, M
    Djang, F
    Balch, AH
    Chou, TC
    Prichard, M
    Colonno, RJ
    Lin, PF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) : 1346 - 1351
  • [23] A highly sensitive chemiluminescent reverse transcriptase assay for human immunodeficiency virus
    Odawara, F
    Abe, H
    Kohno, T
    Nagai-Fujii, Y
    Arai, K
    Imamura, S
    Misaki, H
    Azuma, H
    Ikebuchi, K
    Ikeda, H
    Mohan, S
    Sano, K
    JOURNAL OF VIROLOGICAL METHODS, 2002, 106 (01) : 115 - 124
  • [24] Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase
    LeGrice, SFJ
    Cameron, CE
    Benkovic, SJ
    DNA REPLICATION, 1995, 262 : 130 - 144
  • [25] RIBAVIRIN IS AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    FERNANDEZLARSSON, R
    PATTERSON, JL
    MOLECULAR PHARMACOLOGY, 1990, 38 (06) : 766 - 770
  • [26] Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous
    Wilson, JE
    Wright, LL
    Martin, JL
    Haire, SE
    Ray, PH
    Painter, GR
    Furman, PA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (01): : 20 - 30
  • [27] ENZYMATICALLY ACTIVE FORMS OF REVERSE-TRANSCRIPTASE OF THE HUMAN IMMUNODEFICIENCY VIRUS
    LORI, F
    SCOVASSI, AI
    ZELLA, D
    ACHILLI, G
    CATTANEO, E
    CASOLI, C
    BERTAZZONI, U
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (05) : 393 - 398
  • [28] Interaction of primers with mutant forms of human immunodeficiency virus reverse transcriptase
    Sakharova, OD
    Suturina, OA
    Gudima, SO
    Pokholok, DK
    Yamkovoi, VI
    Kochetkov, SN
    Nevinskii, GA
    MOLECULAR BIOLOGY, 1996, 30 (01) : 143 - 148
  • [29] Effects of cation substitutions on reverse transcriptase and on human immunodeficiency virus production
    Filler, AG
    Lever, AML
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (04) : 291 - 299
  • [30] Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
    Sharma, PL
    Nurpeisov, V
    Hernandez-Santiago, B
    Beltran, T
    Schinazi, RF
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 895 - 919